Column

Does HRT (Hormone Replacement Therapy) Help Menopausal Hair Loss? — Dr. Moriwaki Organizes the Types of Estrogen Preparations and the Role of Stem Cell Conditioned Media2026.07.15

“My hair loss suddenly increased after I entered menopause.” “My part line and crown look more see-through than before.” — These consultations noticeably increase in the clinic from women in their late 40s and 50s. Menopausal hair loss is not simply a matter of aging; it arises against a background where the decline of estrogen changes the hair cycle and the scalp environment substantially over a short period. Recently, alongside consultations about HRT (Hormone Replacement Therapy) in gynecology, we hear more questions like “If I start HRT, will my hair come back too?” — but an immediate “yes” would not be an honest answer. This article, from Dr. Moriwaki, organizes how far HRT can be an ally for menopausal hair loss, what changes with different preparations, and how stem cell conditioned media can complement the follicular changes that HRT alone cannot fully cover.

Key Points of This Article

・Menopausal hair loss mainly reflects a shortened hair cycle from estrogen decline and a relative androgen dominance.

・The primary purpose of HRT is to address vasomotor, bone, and urogenital symptoms; effects on hair are secondary with large individual variability.

・Preparation type (oral/transdermal, estradiol/conjugated, and the properties of the co-administered progestin) can change the impact on hair.

・For those without an indication for HRT, or who prefer not to use it, stem cell conditioned media can be a complementary option that acts directly on the follicular environment.

・Avoid self-decision — an order in which the gynecologist and hair specialist evaluate together is preferable.

Background of Menopausal Hair Loss — Estrogen and the Hair Cycle

Hair repeats a cycle of anagen, catagen, and telogen phases, and to maintain thick and long hair, the anagen phase needs to be maintained for a certain length. Estrogen is thought to act in the direction of extending this anagen phase, and it also influences the peri-follicular environment of the hair follicle stem cells and the activity of keratinocytes. When circulating estrogen drops sharply around menopause, the anagen phase shortens and the proportion of hairs entering telogen increases. As a result, changes such as an increase in daily shedding, thinning of hair caliber, and a see-through appearance at the part line accumulate over a short period.

Furthermore, the decline in estrogen creates a state where the influence of androgens becomes “relatively stronger.” Even when the circulating testosterone level itself has not risen, the balance of sensitivity at the follicle can shift, and an AGA-like pattern may appear at the hairline and crown. This is what is called FAGA (female pattern hair loss). In addition, the scalp itself changes in dermal collagen content and sebum secretion, and the microenvironment supporting the follicle becomes leaner — a point that cannot be ignored. In medical terms, menopausal hair loss should be understood as a result of multiple axes — hormones, hair cycle, and scalp environment — moving at the same time.

How HRT (Hormone Replacement Therapy) Can Relate to Hair Loss

The primary purpose of HRT is to address vasomotor symptoms such as hot flashes and sweating, urogenital symptoms such as atrophic vaginitis, and prevention of loss of bone mineral density — it is not approved as a “hair-loss treatment.” That said, among observational studies and small analyses, there are reports that women continuing HRT showed a more gradual decline in hair density. Even so, this is only a secondary observation and does not mean “if you start HRT, your hair will surely grow.” Effects vary greatly between individuals, and results also change depending on the timing of initiation, route of administration, and choice of preparation. When layering HRT for hair reasons, the systemic indication always comes first, and above it the influence on hair should be evaluated with a posture of “neither over-expecting nor giving up.”

What to Expect Differs by Oral, Transdermal, and Preparation Type

Even with the same estrogen replacement, the behavior in the body differs between oral and transdermal routes. Oral estrogen passes through the liver, raising SHBG (sex hormone-binding globulin) and acting in the direction of relatively lowering free testosterone. This action can, in theory, work favorably for hair concerns involving androgen dominance. On the other hand, transdermal preparations (patch or gel) avoid first-pass through the liver, so SHBG movement is small and anti-androgenic effects are milder. Transdermal preparations are, however, superior in safety in terms of venous thromboembolism risk, and one cannot choose a preparation solely on the basis of hair effects. It is a matter to decide with the obstetrician-gynecologist within the overall context of safety and indication.

The Pitfall of the Androgenic Activity of Progestins

For women with a uterus, a progestin is co-administered with estrogen to protect the endometrium. What is often overlooked here is that the androgenic activity differs by the type of progestin. Norethisterone and levonorgestrel carry androgenic activity, and considering effects on hair, they are not necessarily neutral. In contrast, natural progesterone and drospirenone are considered anti-androgenic or neutral. In women whose hair loss symptoms are pronounced, the choice of co-administered progestin can be unexpectedly important, and it is information worth sharing with the gynecologist.

menopause women hair thinning scalp stem cell

Changes in the Follicle That HRT Alone Does Not Cover, and Stem Cell Conditioned Media as an Option

HRT cannot be used by every woman. If there is a history of breast cancer or endometrial cancer, active venous thromboembolism, or uncontrolled hepatic dysfunction, HRT is not an option. In addition, many women hold the value that they would rather not depend on hormone preparations if possible. In such situations, a scalp-side approach that supports the follicular environment can be considered — namely, scalp treatment with stem cell conditioned media. Stem cell conditioned media contains cytokines and growth factors such as VEGF, IGF-1, HGF, and TGF-β, which may relate to angiogenesis and activation of dermal papilla cells. The aim of this treatment is to deliver these locally to the scalp and act on the microenvironment surrounding the follicle itself. However, stem cell conditioned media is not a treatment that changes the systemic hormonal environment. Therefore, it does not address menopausal symptoms themselves, and should be honestly positioned as a complementary option focused on the scalp and follicle.

The Order to Begin Treatment for Menopausal Hair Loss and Points to Note

The first step in the clinical order is a menopausal assessment at gynecology (symptom scoring, hormone levels) and background systemic tests (thyroid function, ferritin, anemia, hepatic/renal function, etc.). Behind hair thinning in menopause, there are actually many cases where other internal factors such as hypothyroidism or iron deficiency overlap, and if these are overlooked while stacking scalp treatments alone, the response tends to be poor. If there is a gynecological indication, HRT is considered, and the properties of the co-administered progestin are also taken into account as needed. If concerns about hair still remain, combining scalp treatment with stem cell conditioned media as a scalp-side approach is a natural order. Effect evaluation is on the order of months due to the hair cycle, and transient shedding may temporarily increase early on. Effects vary between individuals, and for advanced scarring alopecia or areas where the follicles have been completely lost, recovery has limits with any treatment. From our list of hair regenerative medicine columns here, you can find other articles on menopause and female hair loss. For clinical guidance on AGA and hair loss, please also refer to the guidelines of the Japanese Dermatological Association.

Frequently Asked Questions

Q. Will menopausal hair loss surely improve once I start HRT?

Not always. The main purpose of HRT is to address systemic symptoms such as hot flashes and to prevent osteoporosis; effects on hair are secondary with large individual variability. Results change with the timing of initiation, route of administration, and the type of co-administered progestin. A posture of “neither over-expecting nor giving up” is important.

Q. I have a history of breast cancer and cannot use HRT. What should I do about hair concerns?

Even when HRT is not an option, there is much you can do — nutritional evaluation (iron, ferritin, protein), a thyroid function check, and care of the scalp environment. As a hair treatment that does not intervene in hormones, scalp treatment with stem cell conditioned media can also be considered complementarily. Please structure options that can safely be pursued in consultation with your attending physician.

Q. Can scalp treatment with stem cell conditioned media be combined while receiving HRT?

Combination is generally possible, but please always share the content of the other treatment with the attending physicians on both the gynecology and hair sides. Since the period right after starting HRT is one when physical condition can fluctuate, it is safer to decide the timing of the procedure after your condition has stabilized.

Q. How long before I can feel the effect?

Due to the hair cycle, sensible change takes at least three months, and change in density is evaluated around six months as a guide. Transient shedding may increase at 2 to 8 weeks after starting; this is a phenomenon due to hair cycle synchronization and is not necessarily a sign of failure. We recommend also following the course with objective indices such as fixed-point photos and hair caliber measurement.

──────────────

Supervising Physician: Shin Moriwaki, MD

Member of the Japan Society of Aesthetic Surgery (JSAS) / Member of the American Academy of Aesthetic Medicine

ECFMG Certificate

──────────────

📍AVAN TOKYO Ginza Hair Regenerative Medicine

AVAN TOKYO Ginza Hair Regenerative Medicine

English / 中文 / Tiếng Việt supported

Inquiries welcome via DM / LINE / Website / Phone.